Hartmann Jessica A, McGorry Patrick D, Destree Louise, Amminger G Paul, Chanen Andrew M, Davey Christopher G, Ghieh Rachid, Polari Andrea, Ratheesh Aswin, Yuen Hok Pan, Nelson Barnaby
Orygen, Parkville, VIC, Australia.
Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia.
Front Psychiatry. 2021 Jan 8;11:553578. doi: 10.3389/fpsyt.2020.553578. eCollection 2020.
Most psychiatric disorders develop during adolescence and young adulthood and are preceded by a phase during which attenuated or episodic symptoms and functional decline are apparent. The introduction of the ultra-high risk (UHR) criteria two decades ago created a new framework for identification of risk and for pre-emptive psychiatry, focusing on first episode psychosis as an outcome. Research in this paradigm demonstrated the comorbid, diffuse nature of emerging psychopathology and a high degree of developmental heterotopy, suggesting the need to adopt a broader, more agnostic approach to risk identification. Guided by the principles of clinical staging, we introduce the concept of a pluripotent at-risk mental state. The clinical high at risk mental state (CHARMS) approach broadens identification of risk beyond psychosis, encompassing multiple exit syndromes such as mania, severe depression, and personality disorder. It does not diagnostically differentiate the early stages of psychopathology, but adopts a "pluripotent" approach, allowing for overlapping and heterotypic trajectories and enabling the identification of both transdiagnostic and specific risk factors. As CHARMS is developed within the framework of clinical staging, clinical utility is maximized by acknowledging the dimensional nature of clinical phenotypes, while retaining thresholds for introducing specific interventions. Preliminary data from our ongoing CHARMS cohort study ( = 114) show that 34% of young people who completed the 12-month follow-up assessment ( = 78) transitioned from Stage 1b (attenuated syndrome) to Stage 2 (full disorder). While not without limitations, this broader risk identification approach might ultimately allow reliable, transdiagnostic identification of young people in the early stages of severe mental illness, presenting further opportunities for targeted early intervention and prevention strategies.
大多数精神疾病在青少年期和青年期发病,在此之前会有一个阶段,症状减弱或呈发作性,功能也会出现衰退。二十年前引入的超高风险(UHR)标准为风险识别和预防性精神病学创建了一个新框架,重点关注首次发作的精神病这一结果。该范式下的研究表明,新出现的精神病理学具有共病、弥漫性的特点,且发育异位程度较高,这表明需要采用更广泛、更不确定的风险识别方法。在临床分期原则的指导下,我们引入了多能风险精神状态的概念。临床高风险精神状态(CHARMS)方法将风险识别范围扩大到精神病之外,涵盖了多种转归综合征,如躁狂症、重度抑郁症和人格障碍。它并不对精神病理学的早期阶段进行诊断区分,而是采用“多能”方法,允许轨迹重叠和异型,从而能够识别跨诊断和特定的风险因素。由于CHARMS是在临床分期框架内开发的,通过承认临床表型的维度性质,同时保留引入特定干预措施的阈值,可将临床效用最大化。我们正在进行的CHARMS队列研究(n = 114)的初步数据显示,完成12个月随访评估的年轻人(n = 78)中,34%从1b期(症状减弱综合征)转变为2期(完全疾病状态)。尽管存在局限性,但这种更广泛的风险识别方法最终可能使我们能够可靠地跨诊断识别处于严重精神疾病早期阶段的年轻人,为有针对性的早期干预和预防策略提供更多机会。